tiprankstipranks
Sartorius Stedim Biotech (MX:DIMN)
:DIMN
Mexico Market
DIMN
Sartorius Stedim Biotech
RESEARCH TOOLSreports

Sartorius Stedim Biotech (DIMN) Ratios

0 Followers

Sartorius Stedim Biotech Ratios

MX:DIMN's free cash flow for Q2 2026 was €0.47. For the 2026 fiscal year, MX:DIMN's free cash flow was decreased by € and operating cash flow was €0.21. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.16 1.02 1.85 1.51 1.61
Quick Ratio
 0.55 0.53 1.12 0.57 0.62
Cash Ratio
 0.17 0.30 0.72 0.12 0.10
Solvency Ratio
 0.17 0.15 0.11 0.11 0.41
Operating Cash Flow Ratio
 0.53 0.38 0.87 0.67 0.59
Short-Term Operating Cash Flow Coverage
 1.95 0.97 20.58 10.91 136.07
Net Current Asset Value
€ -2.32B€ -2.45B€ -2.49B€ -3.65B€ -880.00M
Leverage Ratios
Debt-to-Assets Ratio
 0.30 0.32 0.35 0.48 0.22
Debt-to-Equity Ratio
 0.57 0.64 0.72 1.40 0.46
Debt-to-Capital Ratio
 0.36 0.39 0.42 0.58 0.32
Long-Term Debt-to-Capital Ratio
 0.31 0.31 0.40 0.57 0.29
Financial Leverage Ratio
 1.87 1.96 2.07 2.93 2.07
Debt Service Coverage Ratio
 1.56 1.07 3.17 3.73 23.74
Interest Coverage Ratio
 3.25 3.60 2.33 4.00 24.27
Debt to Market Cap
 0.12 0.12 0.15 0.16 0.04
Interest Debt Per Share
 26.53 28.28 31.29 41.27 12.77
Net Debt to EBITDA
 2.48 2.51 3.27 4.72 0.77
Profitability Margins
Gross Profit Margin
44.87%45.33%43.41%44.44%52.52%
EBIT Margin
18.74%18.50%13.27%18.70%32.90%
EBITDA Margin
29.50%29.22%24.12%27.23%38.10%
Operating Profit Margin
19.38%18.50%13.33%17.46%28.49%
Pretax Profit Margin
13.68%12.58%7.88%14.45%32.36%
Net Profit Margin
9.74%8.95%6.30%11.16%25.08%
Continuous Operations Profit Margin
9.77%8.96%6.42%11.24%25.19%
Net Income Per EBT
71.19%71.17%79.88%77.21%77.50%
EBT Per EBIT
70.56%67.98%59.15%82.79%113.59%
Return on Assets (ROA)
3.70%3.31%2.12%4.00%17.30%
Return on Equity (ROE)
7.11%6.49%4.39%11.74%35.77%
Return on Capital Employed (ROCE)
8.63%8.31%5.06%7.12%24.70%
Return on Invested Capital (ROIC)
5.89%5.44%4.09%5.48%19.11%
Return on Tangible Assets
8.30%7.38%4.71%9.80%28.70%
Earnings Yield
1.52%1.30%0.96%1.40%3.14%
Efficiency Ratios
Receivables Turnover
 9.16 13.06 10.42 9.45 8.34
Payables Turnover
 5.74 5.84 5.08 5.97 6.59
Inventory Turnover
 2.32 2.35 2.30 1.75 1.62
Fixed Asset Turnover
 1.46 1.47 1.47 1.70 2.70
Asset Turnover
 0.38 0.37 0.34 0.36 0.69
Working Capital Turnover Ratio
 26.38 7.14 4.34 4.99 6.63
Cash Conversion Cycle
 133.61 120.91 122.00 186.30 213.96
Days of Sales Outstanding
 39.86 27.96 35.03 38.62 43.75
Days of Inventory Outstanding
 157.38 155.45 158.89 208.87 225.58
Days of Payables Outstanding
 63.63 62.51 71.92 61.19 55.36
Operating Cycle
 197.25 183.41 193.92 247.49 269.32
Cash Flow Ratios
Operating Cash Flow Per Share
 6.32 5.54 8.42 6.83 6.64
Free Cash Flow Per Share
 2.27 1.49 4.91 1.69 1.97
CapEx Per Share
 4.05 4.04 3.51 5.14 4.67
Free Cash Flow to Operating Cash Flow
 0.36 0.27 0.58 0.25 0.30
Dividend Paid and CapEx Coverage Ratio
 1.33 1.17 2.00 1.04 1.12
Capital Expenditure Coverage Ratio
 1.56 1.37 2.40 1.33 1.42
Operating Cash Flow Coverage Ratio
 0.26 0.21 0.28 0.17 0.54
Operating Cash Flow to Sales Ratio
 0.20 0.18 0.29 0.23 0.18
Free Cash Flow Yield
1.15%0.71%2.60%0.71%0.65%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 65.53 76.92 104.29 71.27 31.82
Price-to-Sales (P/S) Ratio
 6.41 6.89 6.57 7.95 7.98
Price-to-Book (P/B) Ratio
 4.54 5.00 4.58 8.37 11.38
Price-to-Free Cash Flow (P/FCF) Ratio
 87.24 140.53 38.42 141.40 153.44
Price-to-Operating Cash Flow Ratio
 31.30 37.94 22.40 35.05 45.53
Price-to-Earnings Growth (PEG) Ratio
 2.09 1.51 -2.26 -1.10 0.29
Price-to-Fair Value
 4.54 5.00 4.58 8.37 11.38
Enterprise Value Multiple
 24.20 26.07 30.50 33.93 21.72
Enterprise Value
 21.45B 22.61B 20.45B 25.64B 28.91B
EV to EBITDA
 24.20 26.07 30.50 33.93 21.72
EV to Sales
 7.14 7.62 7.36 9.24 8.28
EV to Free Cash Flow
 97.21 155.48 43.03 164.24 159.10
EV to Operating Cash Flow
 34.88 41.97 25.09 40.71 47.21
Tangible Book Value Per Share
 -1.51 -3.03 -5.33 -20.78 5.43
Shareholders’ Equity Per Share
 43.55 42.04 41.19 28.63 26.58
Tax and Other Ratios
Effective Tax Rate
 0.29 0.29 0.19 0.22 0.22
Revenue Per Share
 30.89 30.50 28.73 30.12 37.90
Net Income Per Share
 3.01 2.73 1.81 3.36 9.51
Tax Burden
 0.71 0.71 0.80 0.77 0.78
Interest Burden
 0.73 0.68 0.59 0.77 0.98
Research & Development to Revenue
 0.05 0.04 0.05 0.05 0.04
SG&A to Revenue
 0.22 0.22 0.23 0.06 0.04
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 2.10 2.03 3.72 2.03 0.54
Currency in EUR